Jpmorgan Chase & CO Grifols Sa Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Grifols Sa stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,988,043 shares of GRFS stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,988,043
Previous 2,002,511 0.72%
Holding current value
$16.8 Million
Previous $17.8 Million 16.82%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$6.99 - $9.55 $101,131 - $138,169
-14,468 Reduced 0.72%
1,988,043 $14.8 Million
Q3 2024

Dec 26, 2024
BUY
$6.28 - $9.38 $7.42 Million - $11.1 Million
1,181,959 Added 144.04%
2,002,511 $17.8 Million
Q3 2024

Nov 08, 2024
BUY
$6.28 - $9.38 $7.42 Million - $11.1 Million
1,181,959 Added 144.04%
2,002,511 $17.8 Million
Q2 2024

Dec 26, 2024
SELL
$6.27 - $7.7 $7.41 Million - $9.1 Million
-1,181,959 Reduced 59.02%
820,552 $5.17 Million
Q2 2024

Aug 12, 2024
SELL
$6.27 - $7.7 $1.45 Million - $1.78 Million
-231,723 Reduced 22.02%
820,552 $5.17 Million
Q1 2024

Dec 26, 2024
SELL
$5.47 - $11.38 $5.2 Million - $10.8 Million
-950,236 Reduced 47.45%
1,052,275 $7.03 Million
Q1 2024

May 10, 2024
SELL
$5.47 - $11.38 $4.6 Million - $9.58 Million
-841,504 Reduced 44.44%
1,052,275 $7.03 Million
Q4 2023

Dec 26, 2024
SELL
$7.71 - $11.56 $838,323 - $1.26 Million
-108,732 Reduced 5.43%
1,893,779 $21.9 Million
Q4 2023

Feb 12, 2024
BUY
$7.71 - $11.56 $4.05 Million - $6.07 Million
525,162 Added 38.37%
1,893,779 $21.9 Million
Q3 2023

Nov 14, 2023
BUY
$8.91 - $10.91 $2.93 Million - $3.59 Million
329,372 Added 31.69%
1,368,617 $12.5 Million
Q2 2023

Aug 11, 2023
SELL
$7.14 - $9.29 $6.31 Million - $8.21 Million
-884,256 Reduced 45.97%
1,039,245 $9.52 Million
Q1 2023

May 11, 2023
BUY
$6.65 - $10.69 $2.28 Million - $3.67 Million
342,912 Added 21.7%
1,923,501 $14.2 Million
Q4 2022

Feb 13, 2023
SELL
$5.96 - $8.53 $5.94 Million - $8.5 Million
-995,903 Reduced 38.65%
1,580,589 $13.4 Million
Q3 2022

Nov 14, 2022
SELL
$5.95 - $14.3 $3.14 Million - $7.54 Million
-527,393 Reduced 16.99%
2,576,492 $15.9 Million
Q2 2022

Aug 11, 2022
SELL
$10.6 - $13.28 $1.06 Million - $1.33 Million
-100,030 Reduced 3.12%
3,103,885 $36.9 Million
Q1 2022

May 11, 2022
SELL
$10.37 - $12.73 $780,031 - $957,550
-75,220 Reduced 2.29%
3,203,915 $37.4 Million
Q4 2021

Feb 10, 2022
SELL
$10.21 - $15.27 $3.39 Million - $5.07 Million
-332,150 Reduced 9.2%
3,279,135 $36.8 Million
Q3 2021

Nov 12, 2021
BUY
$14.07 - $17.3 $50.8 Million - $62.5 Million
3,611,285 New
3,611,285 $52.8 Million

Others Institutions Holding GRFS

# of Institutions
169
Shares Held
145M
Call Options Held
166K
Put Options Held
103K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.73B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email